Richard B. Fried, 10% Owner at Nexvet Biopharma plc (NVET), bought 11,100 shares at $5.75 ($72K) on 2015-09-09, disclosed to the SEC on 2015-09-11.
Open-market purchase of $72k NVET by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.75 | 5 | $29 | 0.0% |
| 2 | $5.75 | 8 | $46 | 0.1% |
| 3 | $5.75 | 9 | $52 | 0.1% |
| 4 | $5.75 | 31 | $178 | 0.2% |
| 5 | $5.75 | 34 | $196 | 0.3% |
| 6 | $5.75 | 35 |
| $201 |
| 0.3% |
| 7 | $5.75 | 78 | $449 | 0.6% |
| 8 | $5.75 | 100 | $575 | 0.8% |
| 9 | $6.48 | 166 | $1K | 1.5% |
| 10 | $6.48 | 285 | $2K | 2.6% |
| 11 | $6.48 | 339 | $2K | 3.1% |
| 12 | $6.48 | 1,133 | $7K | 10.2% |
| 13 | $6.48 | 1,222 | $8K | 11.0% |
| 14 | $6.48 | 1,245 | $8K | 11.3% |
| 15 | $6.48 | 2,810 | $18K | 25.4% |
| 16 | $6.48 | 3,600 | $23K | 32.5% |
| Total | $6.46 avg | 11,100 | $72K | 100% |
| Filing → |
| PLYA | SELL | 2021-05-21 | $91.4M | — | Filing → |
| PLYA | SELL | 2020-11-24 | $128.0M | — | Filing → |
| HPP | SELL | 2017-11-09 | $1.2M | — | Filing → |